logo

CT MEDICAL MARIJUANA QUALIFYING CONDITIONS

Mar 08, 2024
misc image
A patient may only register for a medical marijuana certificate if he or she is a Connecticut resident being treated for a debilitating medical condition by a Connecticut-licensed physician or advanced practice registered nurse.

QUALIFYING CONDITIONS FOR MEDICAL MARIJUANA IN CT

A patient may only register for a medical marijuana certificate if he or she is a Connecticut resident being treated for a debilitating medical condition by a Connecticut-licensed physician or advanced practice registered nurse. 

For Adults, Debilitating Medical Conditions Include:

  • Cancer (Effective 2012)
  • Glaucoma (Effective 2012)
  • Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012)
  • Parkinson’s Disease (Effective 2012)
  • Multiple Sclerosis (Effective 2012)
  • Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)
  • Epilepsy (Effective 2012)
  • Cachexia (Effective 2012)
  • Wasting Syndrome (Effective 2012)
  • Crohn’s Disease (Effective 2012)
  • Post-Traumatic Stress Disorder (Effective 2012)
  • Sickle Cell Disease (Effective 2016)*
  • Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*
  • Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*
  • Amyotrophic Lateral Sclerosis (Effective 2016)*
  • Ulcerative Colitis (Effective 2016)*
  • Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*
  • Cerebral Palsy (Effective 2016)
  • Cystic Fibrosis (Effective 2016)
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)
  • Terminal Illness Requiring End-Of-Life Care (Effective 2016)
  • Uncontrolled Intractable Seizure Disorder (Effective 2016)
  • Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*
  • Severe Rheumatoid Arthritis (Effective 2018)*
  • Post Herpetic Neuralgia (Effective 2018)*
  • Hydrocephalus with Intractable Headache (Effective 2018)*
  • Intractable Headache Syndromes (Effective 2018)*
  • Neuropathic Facial Pain (Effective 2018)*
  • Muscular Dystrophy (Effective 2018)*
  • Osteogenesis Imperfecta (Effective 2018)*
  • Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*
  • Interstitial Cystitis (Effective 2019)*
  • MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*
  • Vulvodynia and Vulvar Burning (Effective 2019)*
  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*
  • Tourette Syndrome (Effective 2019)*
  • Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*
  • Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*